Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis

Kidney International

Volumn 53, Issue 2, 1998, Pages 253-263

  Heeringa, Peter ^a   Brouwer, Elisabeth ^b   Tervaert, Jan Willem Cohen ^b   Weening, Jan J ^b   Kallenberg, Cees G M ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

ANCA associated vasculitis; Monocytes and ANCA; Neutrophil activation by ANCA; Vasculitis

Indexed keywords

IMMUNOGLOBULIN IDIOTYPE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

GLOMERULONEPHRITIS; IMMUNOPATHOGENESIS; LEUKOCYTE ACTIVATION; NECROTIZING ARTERITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0031932740     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00743.x     Document Type: Article

References (121)

1. DAVIES D, MORAN ME, NIALL JF, RYAN GB: Segmental glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology. Brit J Med 285:606, 1992
2. VAN DER WOUDE FJ, RASMUSSEN N, LOBATTO S, WIIK A, PERMIN H, VAN ES LA, VAN DER GIESSEN M, HEM GK, THE TH: Autoantibodies to neutrophils and monocytes: A new tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet i:425-429, 1985
3. COHEN TERVAERT JW, GOLDSCHMEDING R, VON DEM BORNE AEGK, KALLENBERG CGM: Anti-myeloperoxidase antibodies in the Churg Strauss syndrome. Thorax 46:70-71, 1991
4. GUILLEVIN L, VISSER H, NOEL LH, POURRAT J, VERNIER I, GAYRAUD M, OKSMAN F, LESAVRE P: Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B infection and Churg-Strauss syndrome. J Rheumatol 20:1345-1349, 1993
5. GASKIN G, SAVAGE COS, RYAN JJ, JONES S, LOCKWOOD CM: Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vascultis. Nephrol Dial Transplant 6:689-694, 1991
6. FALK RJ, JENNETTE JC: Anti-neutrophil cytoplasmic autoantibodies with specificty for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318:1651-1657, 1988
7. COHEN TERVAERT JW, GOLDSCHMEDING R, ELEMA JD, VAN DER GIESSEN M, HUITEMA MG, VAN DER HEM GK, THE TH, VON DEM BORNE AEGK, KALLENBERG CGM: Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 37: 799-806, 1990
8. GOLDSCHMEDING R, VAN DER SCHOOT CE, TEN BOKKEL-HUININK D, HACK CE, VAN DEN ENDE CE, KALLENBERG CGM, VON DEM BORNE AEGK: Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 84:1577-1587, 1989
9. NILES JL, MCCLUSKEY RT, AHMAD MF, ARNAOUT MA: Wegener's autoantigen is a novel neutrophil serine protease. Blood 74:1888-1893, 1989
10. LÜDEMANN J, UTECHT B, GROSS WL: Anti-neutrophil cytoplasmic antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 171:357-362, 1990
11. KALLENBERG CGM, BROUWER E, WEENING JJ, COHEN TERVAERT JW: Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int 46:1-15, 1994
12. SPECKS U, WHEATLEY CL, MCDONALD TJ, ROHRBACH MS, DEREMEE RA: Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis. Mayo Clin Proc 64:28-36, 1989
13. COHEN TERVAERT JW, HUITEMA MG, HENE RJ, SLUITER WJ, THE TH, VAN DER HEM GK, KALLENBERG CGM: Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336:709-711, 1990
14. EGNER W, CHAPEL HM: Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immunol 82:244-249, 1990
15. JAYNE DRW, HEATON A, BROWNLEE A, LOCKWOOD CM: Sequential antineutrophil cytoplasm antibody titres in the management of systemic vasculitis. Nephrol Dial Transplant 5:309-310, 1990
16. RAO JK, WEINBERGER M, ODDONE EZ, ALEN NB, LANDSMAN P, FEUSSNER JR: The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener's granulomatosis. Ann Intern Med 123:925-932, 1995
17. KETTRITZ R, YANG JJ, KINJOH K, JENNETTE JC, FALK RJ: Animal models in ANCA-vasculitis. Clin Exp Immunol 101:12-15, 1995
18. FALK RJ, TERRELL RS, CHARLES LA, JENNETTE JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87:4115-4119, 1990
19. WEISS SJ: Tissue destruction by neutrophils. N Engl J Med 320:365-376, 1989
20. KEOGAN MT, RIFKIN I, LOCKWOOD CM, BROWN DL: Antineutrophil cytoplasm antibodies increase neutrophil adhesion to cultured human endothelium. Adv Exp Med Biol 336:115-119, 1993
21. VARGUNAM M, ADU D, TAYLOR CM, MICHAEL J, RICHARDS N, NEUBERGER J, THOMPSON RA: Endothelium myeloperoxidase-anti-myeloperoxidase interaction in vasculitis. Nephrol Dial Transplant 7:1077-1081, 1995
22. EWERT BH, JENNETTE JC, FALK RJ: Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 41:375-383, 1992
23. SAVAGE CO, POTTINGER BE, GASKIN G, PUSEY CD, PEARSON JD: Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity towards cultured endothelial cells. Am J Pathol 141:335-342, 1992
24. GRIMMINGER F, HATTAR K, PAPAVASSILIS C, TEMMESFELD B, CSERNOK E, GROSS WL, SEEGER W, SIBELIUS U: Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: Role of exogenous arachidonic acid and leukotriene B4 generation. J Exp Med 184:1567-1572, 1996
25. BROOKS CJ, KING WJ, RADFORD DJ, ADU D, MCGRATH M, SAVAGE COS: IL-1beta production by human polymorphonuclear leukocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: Relevance to systemic vasculitis. Clin Exp Immunol 106:273-279, 1996
26. MYERS CR, O'DONOGHUE DJ, BRENCHLEY PEC: ANCA stimulates PMN cytokine production. (abstract) J Am Soc Nephrol 6:844, 1995
27. CHURG J, CHURG A: Idiopathic and secondary vasculitis: A review. Modern Pathol 2:144-160, 1989
28. CASSATELLA MA: The production of cytokines by polymorphonuclear leukocytes. Immunol Today 16:21-26, 1995
29. CSERNOK E, ERNST M, SCHMITT W, BAINTON DF, GROSS WL: Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 95:244-250, 1994
30. GILLIGAN HM, BREDY B, BRADY HR, HEBERT MJ, SLAYTER HS, XU Y, RAUCH J, SHIA MA, KOH JS, LEVINE JS: Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 184:2231-2241, 1996
31. MULDER AHL, HEERINGA P, BROUWER E, LIMBURG PC, KALLENBERG CGM: Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA); a FcgammaRII-dependent process. Clin Exp Immunol 78:270-278, 1994
32. PORGES AJ, REDECHA PB, KIMBERLEY WT, CSERNOK E, GROSS WL, KIMBERLEY RP: Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via FcgammaRIIa. J Immunol 153:1271-1280, 1994
33. REUMAUX D, VOSSEBELD PJM, ROOS D, VERHOEVEN AJ: Effects of tumor necrosis factor-induced integrin activation on Fcgamma receptor II-mediated signal transduction: Relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 86:3189-3195, 1995
34. KEOGAN MT, ESNAULT VLM, GREEN AJ, LOCKWOOD CM, BROWN DL: Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 90:228-234, 1992
35. KETTRITZ R, JENNETTE JC, FALK RJ: Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol 8:386-394, 1997
36. FALK RJ, HOGAN S, CAREY TS, JENNETTE JC: Clinical course of antineutrophil cytoplasmic autoantbodies-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 113:656-663, 1990
37. PINCHING AJ, REES AJ, PUSSEL BA, LOCKWOOD CM, MITCHISON RS, PETERS DK: Relapses in Wegener's granulomatosis; The role of infections. Br Med J 281:836-838, 1980
38. STEGEMAN CA, COHEN TERVAERT JW, SLUITER WJ, MANSON W, DE JONG PE, KALLENBERG CGM: Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 113:12-17, 1994
39. MULLER KOBOLD AC, MESANDER G, KALLENBERG CGM, COHEN TERVAERT JW: Activated circulating neutrophils in relation to disease activity in ANCA-associated vasculitits. (abstract) Nephrol Dial Transplant 11:1690, 1996
40. EWERT BH, JENNETTE JC, FALK RJ: The pathogenic role of antineutrophil cytoplasmic autoantibodies. Am J Kidney Dis 18:188-195, 1991
41. CASSELMAN BL, KILGORE KS, MILLER BF, WARREN JS: Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. J Lab Clin Med 126:495-502, 1995
42. BALLIEUX BEPB, HIEMSTRA PS, KLAR-MOHAMAD N, HAGEN EC, VAN ES LA, VAN DER WOUDE FJ, DAHA MR: Detachment and cytolysis of human endothelial cells by proteinase 3. Eur J Immunol 24:3211-3215, 1994
43. BALLIEUX BEPB, ZONDERVAN KT, KIEVIT P, HAGEN EC, VAN ES LA, VAN DER WOUDE FJ, DAHA MR: Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA mediated endothelial damage through ADCC? Clin Exp Immunol 97:52-60, 1994
44. MAYET WJ, CSERNOK E, SZYMKOWIAK C, GROSS WL, MEYER ZUM BUSCHENFELDE KH: Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 82:1221-1229, 1993
45. MAYET WJ, MEYER ZUM BUSCHENFELDE KH: Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol 94:440-446, 1993
46. MAYET WJ, SCHWARTING A, MEYER ZUM BUSCHENFELDE KH: Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells. Clin Exp Immunol 97:458-465, 1994
47. KING WJ, ADU D, DAHA MR, BROOKS DJ, RADFORD DJ, PALL AA, SAVAGE COS: Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3. Clin Exp Immunol 102:98-105, 1995
48. HORN RG, FAUCI AS, ROSENTHAL AS, WOLFF SM: Renal biopsy pathology in Wegener's Granulomatosis. Am J Pathol 74:423-440, 1974
49. GERMUTH FG, VALDES AJ, TAYLOR JJ, WISE OL, RODRIGUEZ E: Fatal immune complex glomerulonephritis without immune deposits. John Hopkins Med J 136:189-192, 1975
50. STILMANT MM, BOLTON WK, STURGILL BG, SCHMITT GW, COUSER WG: Crescentic glomerulonephritis without immune deposits; Clinicopathologic features. Kidney Int 15:184-195, 1979
51. RONCO P, VERROUST P, MIGNON F, KOURILSKY O, VANHILLE P, MEYRIER A, MERY JP, MOREL-MAROGER L: Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: A report of 43 patients with 51 biopsies. Quart J Med 10:141-148, 1983
52. GERHARDT GN, AHMAD M, TUBBS RR: Pulmonary vasculitis (Wegener's granulomatosis); Immunohistochemical study of T and B cell markers. Am J Med 74:700-704, 1983
53. BERGE TEN RJM, WILMINK JM, MEIJER CJLM, SURACHNO S, VEEN TEN JH, BALK AG, SCHELLEKENS PTA: Clinical and immunological follow-up in patients with severe renal disease in Wegener's granulomatosis. Am J Nephrol 5:21-29, 1985
54. RASTALDI MP, FERRARIO F, TUNESI S, YANG L, D'AMICO G: Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1alpha expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis. Am J Kidney Dis 27:48-57, 1996
55. MATHIESON PW, OLIVEIRA DBG: The role of cellular immunity in systemic vasculitis. Clin Exp Immunol 100:183-185, 1995
56. STEGEMAN CA, COHEN TERVAERT JW, HUTTEMA MG, KALLENBERG CGM: Serum markers of T-cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol 91:415-420, 1993
57. SCHMITT WH, HEESEN C, CSERNOK E: Elevated serum levels of soluble interleukin-2-receptor (sIL-2R) in Wegener's granulomatosis. Arthr Rheum 35:108-110, 1993
58. VAN DER WOUDE FJ, VAN ES LA, DAHA MR: The role of the c-ANCA antigen in the pathogenesis of Wegener's granulomatosis. Neth J Med 36:169-171, 1990
59. PETERSEN J, RASMUSSEN N, SZPIRT W, HERMANN E, MAYET W: T lymphocyte proliferation to neutrophil cytoplasmic antigen(s) in Wegener's granulomatosis (WG). Am J Kidney Dis 18:205-209, 1991
60. BALLIEUX BEPB, VAN DER BURG SH, HAGEN EC, VAN DER WOUDE FJ, MELIEF CJM, VAN ES LA, DAHA MR: Cell-mediated autoimmunity in patients with Wegener's granulomatosis. Clin Exp Immunol 100:186-193, 1995
61. BROUWER E, STEGEMAN CA, HUTTEMA MG, LIMBURG PC, KALLENBERG CGM: T-cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis. Clin Exp Immunol 98:448-453, 1994
62. GRIFFITH ME, COULTHART A, PUSEY CD: T cell responses to myeloperoxidase (MPO) and proteinase 3 (Pr3) in patients with systemic vasculitis. Clin Exp Immunol 103:253-258, 1996
63. DEREMEE RA: The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: Illusion or vision? Arthr Rheum 31:1068-1072, 1988
64. RHEINHOLD-KELLER E, BEIGEL A, DUNCKER G, HELLER M, GROSS WL: Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of the disease. Quart J Med 89:15-23, 1996
65. STEGEMAN CA, COHEN TERVAERT JW, DE JONG PE, KALLENBERG CGM: Trimethoprim (Co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 335:16-20, 1996
66. FLEISCHER B, SCHREZENMEIER H: T cell stimulation by Stahylococcal enterotoxins. J Exp Med 167:1697-1707, 1988
67. FRASER JD: High-affinity binding of Staphylococcal enterotoxin A and B to HLA-DR. Nature 339:221-223, 1989
68. DZIARISKI R: Preferential induction of autoantibody secretion in polyclonal activation by peptidoglycan and lipopolysaccharide. I. in vitro studies. J Immunol 128:1018-1025, 1982
69. DZIARSKI R: Preferential induction of autoantibody secretion in polyclonal activation by peptidoglycan and lipopolysaccharide. II. in vitro studies. J Immunol 128:1026-1030, 1982
70. GISCOMBE R, GRUNEWALD J, NITYANAND S, LEFVERT K: T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis. Clin Exp Immunol 101:213-219, 1995
71. SIMPSON U, SKINNER MA, GEURSEN A, PEAKE JS, ABBOTT WG, FRASER JD, LOCKWOOD CM, TAN PLJ: Peripheral blood T lymphocytes in systemic vasculitis: Increased T cell receptor Vbeta gene usage in microscopic polyarteritis. Clin Exp Immunol 101:220-226, 1995
72. VAN DER WIEL BA, DOLMAN KM, VAN DER MEER-GERRITISEN CH, HACK CE, VON DEM BORNE AEGK, GOLDSCHMEDING R: Interference of Wegener's granulomatosis antoantibodies with neutrophil proteinase 3 activity. Clin Exp Immunol 90:409-414, 1992
73. DAOUK GH, PALSSON R, ARNAOUT MA: Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Kidney Int 47:1528-1536, 1995
74. DOLMAN KM, STEGEMAN CA, VAN DER WIEL BA, HACK CE, VON DEM BORNE AEGK, KALLENBERG CGM, GOLDSCHMEDING R: Relevance of classic anti-neutrophil cytoplasmic autoantibody (c-ANCA)-mediated inhibition of proteinase 3-alpha1-antitrypsin complexation to disease activity in Wegener's granulomatosis. Clin Exp Immunol 93:405-410, 1993
75. HOEDEMAEKER PJ, WEENING JJ: Relevance of experimental models for human nephropathology. Kidney Int 35:1015-1025, 1989
76. DRUET P, PELLETIER L, HIRSCH F, ROSSERT J, PASOUIER R, DRUET E, SAPIN C: Mercury-induced autoimmune glomerulonephritis in animals. Contrib Nephrol 61:120-130, 1988
77. 2 in the rat, its possible role in an experimental autoimmune disease. Eur J Immunol 12:620-625, 1982
78. 2 in the rat. Clin Exp Immunol 126:699-702, 1981
79. PUSEY CD, BOWMAN C, MORGAN A, WEETMAN AP, HARTLEY B, LOCKWOOD CM: Kinetics and pathogenicity of autoantibodies induce by mercuric chloride in the Brown Norway rat. Clin Exp Immunol 81:76-82, 1990
80. SAPIN C, DRUET E, DRUET P: Induction of anti-glomerular basement membrane antibodies in the Brown Norway rat by mercuric chloride. Clin Exp Immunol 28:173-179, 1977
81. WEELNING JJ, FLEUREN GJ, HOEDEMAEKER PJ: Demonstration of antinuclear antibodies in mercuric chloride-induced glomerulopathy in the rat. Lab Invest 39:405-411, 1978
82. 2-induced membranous glomerulopathy. Am J Pathol 146:1467-1480, 1995
83. BERNAUDIN JF, DRUET H, BELAIR MF, PINCHON MC, SAPIN C, DRUET P: Extrarenal immune complex type deposits induced by mercuric chloride in the Brown Norway rat. Clin Exp Immunol 38:265, 1979
84. MATHIESON PW, THIRU S, OLIVEIRA DBG: Mercuric chloride-treated brown Norway rats develop widespread tissue injury including necrotizing vasculitis. Lab Invest 67:121-129, 1992
85. QASIM FJ, MATHIESON PW, THIRU S, OLIVEIRA DBG: Time course and characterization of mercuric chloride induced autoimmunity in the Brown Norway rat. J Autoimmun 8:193-208, 1995
86. ESNAUIT VLM, MATHIESON PW, THIRU S, OLIVEIRA DB, LOCKWOOD CM: Autoantibodies to myeloperoxidase in brown norway rats treated with mercuric chloride. Lab Invent 67:114-120, 1992
87. PELLETIER L, PASQUIER R, ROSSERT J, VIAL MC, MANDET C, DRUET P: Autoreactive T cells in mercury-induced autoimmunity. J Immunol 140:750-754, 1988
88. MATHIESON PW, THIRU S, OLIVEIRA DBG: Regulatory role of OX22+ T cells in mercury-induced autoimmunity in the Brown Norway rat. J Exp Med 177:1309-1316, 1993
89. QASIM FJ, MATHIESON PW, THIRU S, OLIVEIRA DBG: Cyclosporin A exarcebates mercuric chloride-induced vasculitis in the Brown Norway rat. Lab Invest 72:183-191, 1995
90. OLIVIERA DBG, GILLESPIE K, WOLFREYS K, MATHIESON PW, QASIM F, COLEMAN JW: Compounds that induce autoimmunity in the Brown Norway rat sensitize mast cells for mediator release and interleukin-4 expression. Eur J Immunol 8:2259-2264, 1995
91. ZHANG Y, RAMOS BF, JAKSCHIK BA: Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 258:1957-1959, 1992
92. MOLLER A, LIPPERT U, LESSMAN D, KOLDE G, HAMANN K, WELKER P, SCHADENDORF D, ROSENBACH T, LUGER T, CZARMETKI BM: Human mast cells produce IL-8. J Immunol 151:3261-3266, 1993
93. QASIM FJ, MATHIESON PW, SENDO F, THIRU S, OLIVEIRA DBG: Role of neutrophils in the pathogenesis of experimental vasculitis. Am J Pathol 149:81-89, 1996
94. MATHIESON PW, QASIM FJ, ESNAUIT VLM, OLIVEIRA DBG: Animal models of systemic vasculitis. J Autoimmun 6:251-264, 1993
95. HANG L, THEOFILOPOULOS AN, DIXON FJ: A spontaneous rheumatoid arthritis-like disease in MRL/l mice. J Exp Med 155:1690-1701, 1982
96. ANDREWS BS, EISENBERG RA, THEOFILOPOULOS AN, IZUI S, WILSON CB, MCCONAHEY PJ, MURPHY ED, ROTHS JB, DIXON FJ: Spontaneous murine lupus-like syndromes. Clinical and immunoathological manifestations in several strains. J Exp Med 148:1198-1215, 1978
97. HEWICKER M, TRAUTWEIN G: Sequential study of vasculitis in MRL mice. Lab Anim 21:333-341, 1987
98. MOYER CF, STRANDBERG DJ, REINISH CL: Systemic mononuclear cell vasculitis in MRL/lpr mice: A histological and immunocytochemical analysis. Am J Pathol 127:229-242, 1987
99. NARDELLA FA, TELLER DC, IZUI S, MANNIK M: Self-associating IgG-rheumatoid factors in MRL/l autoimmune mice. Arthr Rheum 27:1165-1173, 1984
100. IZUI S, EISENBERG RA: Circulating anti-DNA-rheumatoid factor complexes in MRL/l mice. Clin Immunol Pathol 15:536-551, 1980
101. HARPER JM, LOCKWOOD CM, COOKE A: Anti-neutrophil cytoplasm antibody in MRL-lpr/lpr mice. Clin Exp Immunol 93(Suppl 1):22, 1993
102. WATANABE-FUKUNAGA R, BRANNAN CI, COPELAND NG, JENKINS NA, NAGATA S: Lymphoproliferation disorder in mice by defects in Fas-antigen that mediates apoptosis. Nature 56:314-317, 1992
103. ITOH N, YONEJARA M, MIZUSHIMA S, SAMESHIMA M, HASE A, SETO Y, NAGATA S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991
104. OGASAWARA J, WATANABE-FUKUNAGA R, ADACHI M, MATSUZAWA A, KASUAGAI T, KITAMURA Y: Lethal effect of the anti-Fas antibody in mice. Nature 364:806-809, 1993
105. KINJOH K, KYOGUKO M, GOOD RA: Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis. Proc Natl Acad Sci USA 90:3413-3417, 1993
106. KINJOH K, GOOD RA, NEMOTO K, FALK RJ, JENNETTE JC: SCG/Kj mice develop crescentic glomerulonephritis (CGN), vasculitis and MPO-specific P-ANCA. (abstract) Clin Exp Immunol 101(Suppl 1):53, 1995
107. KINJOH K, GOOD RA, TAYLOR J, NACHMAN P, FALK RJ, JENNETTE JC: Hybridomas from SCG/j mice produce P-ANCA with specificity for myeloperoxidase (MPO) and induce proteinuria in nude mice. (abstract) Clin Exp Immunol 101(Suppl 1):37, 1995
108. NOSE M, NISHIMURA M, ITO MR, ITOH J, SHIBATA T, SUGISAKI T: Arteritis in a novel congenic strain of mice derived from MRL/lpr lupus mice. Am J Pathol 149:1763-1769, 1996
109. BROUWER E, HUITEMA MG, KLOK PA, DE WEERD H, COHEN TERVAERT JW, WEENING JJ, KALLENBERG CGM: Anti-myeloperoxidase associated proliferative glomerulonephritis; an animal model. J Exp Med 177:905-914, 1993
110. BROUWER E, KLOK PA, HUITEMA MG, WEENING JJ, KALLENBERG MCG: Renal ischemia/reperfusion injury contributes to renal damage in experimental anti-myeloperoxidase-associated proliferate glomerulonephritis. Kidney Int 47:1121-1129, 1995
111. YANG JJ, JENNETTE JC, FALK RJ: Immune complex glomerulonephritis is induced in rats immunized with heterologous myeloperoxidase. Clin Exp Immunol 97:466-473, 1994
112. 2 in myeloperoxidase-immunized rats leads to necrotizing vasculitis in the lungs and gut. Am J Pathol 151:131-139, 1997
113. KOBAYASHI K, SHIBATA T, SUGISAKI S: Aggravation of rat nephrotoxic serum nephritis by anti-myeloperoxidase antibodies. Kidney Int 47:454-463, 1995
114. HEERINGA P, BROUWER E, KLOK PA, HUITEMA MG, VAN DEN BORN J, WEENING JJ, KALLENBERG CGM: Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane mediated glomerular injury. Am J Pathol 149:1695-1706, 1996
115. SHOENFELD Y: Idiotypic network, pathogenic autoantibodies and autoimmunity. Clin Exp Immunol 101(Suppl 1):26-28, 1995
116. SHOENFELD Y: Idiotypic induction of autoimmunity: A new aspect of the idiotypic network. FASEB J 8:1296-1301, 1994
117. BLANK M, COHEN J, TODER V, SHOENFELD Y: Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibody. Proc Natl Acad Sci USA 88:3069-3073, 1991
118. BAKIMER R, FISHMAN P, BLANK M, SREDININ B, DJALDETTI M, SHOENFELD Y: Induction of primary antiphospholipid syndrome in mice by immunization with human monoclonal anti-dardiolipin antibody (H-3). J Clin Invest 89:1558-1563, 1992
119. MENDLOVIC S, BROCKE S, SHOENFELD Y, BEN-BASSAT M, MISHORER A, BAKIMER R, MOZES E: Induction of a SLE-like disease in mice by a common anti-DNA idiotype. Proc Natl Acad Sci USA 85:2260-2264, 1988
120. BLANK M, TOMER Y, STEIN M, KOPOLOVIC J, WIIK A, MERONI PL, CONFORTI G, SHOENFELD Y: Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol 102:120-130, 1995
121. TOMER Y, GILBURD B, BLANK M, LIDER O, HERSHKOVIZ R, FISHMAN P, ZIGELMAN R, MERONI PL, WIIK A, SHOENFELD Y: Characterization of biologically active antineutrophil cyloplasmic antibodies induced in mice. Arthr Rheum 38:1375-1381, 1995